These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 23890075

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
    Singh N.
    Clin Infect Dis; 2001 Mar 01; 32(5):742-51. PubMed ID: 11229841
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    Razonable RR, Rivero A, Rodriguez A, Wilson J, Daniels J, Jenkins G, Larson T, Hellinger WC, Spivey JR, Paya CV.
    J Infect Dis; 2001 Dec 01; 184(11):1461-4. PubMed ID: 11709790
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Strategies for the prevention of cytomegalovirus infection and disease in pediatric liver transplantation recipients.
    Campbell AL, Herold BC.
    Pediatr Transplant; 2004 Dec 01; 8(6):619-27. PubMed ID: 15598337
    [Abstract] [Full Text] [Related]

  • 9. Benefits of cytomegalovirus prophylaxis in solid organ transplantation.
    Pescovitz MD.
    Transplantation; 2006 Jul 27; 82(2 Suppl):S4-8. PubMed ID: 16858270
    [Abstract] [Full Text] [Related]

  • 10. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation.
    Fisher RA.
    Transpl Infect Dis; 2009 Jun 27; 11(3):195-202. PubMed ID: 19228345
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.
    Roman A, Manito N, Campistol JM, Cuervas-Mons V, Almenar L, Arias M, Casafont F, del Castillo D, Crespo-Leiro MG, Delgado JF, Herrero JI, Jara P, Morales JM, Navarro M, Oppenheimer F, Prieto M, Pulpón LA, Rimola A, Serón D, Ussetti P, ATOS working group.
    Transplant Rev (Orlando); 2014 Apr 27; 28(2):84-91. PubMed ID: 24602805
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Management of cytomegalovirus infection and disease after solid-organ transplantation.
    van der Bij W, Speich R.
    Clin Infect Dis; 2001 Jul 01; 33 Suppl 1():S32-7. PubMed ID: 11389520
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.